Back to VA VANGUARD CAPITAL MANAGEMENT LLC
AZN2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ASTRAZENECA PLC
Yes. Vanguard Capital Management holds 45,386,190 shares of AZN (AstraZeneca), worth $8.5B, as of its Q2 2026 13F filing. It increased the position by 346,048 shares (+0.8%) from Q1 2026. Vanguard Capital Management has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.2% of Vanguard Capital Management's reported 13F portfolio.
Current Value
$8.5B
Current Shares
45.4M
Total Value Change
-$333.4M
Total Shares Change
+346,048
Quarter-by-Quarter History
Other major holders of AZN: Capital International Investors, NORGES BANK, FMR LLC, Capital World Investors